Effects of Ginaton combined with batroxobin on oxidative stress, hemodynamics and coagulation in SHL patients
Objective: To investigate the effects of ginaton combined with batroxobin on oxidative stress, hemodynamics and coagulation in patients with sudden hearing loss. Methods: According to random data table method, 100 cases of sudden hearing loss were randomly divided into the control group (n=50) an...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Board of Journal of Hainan Medical University
2017-11-01
|
Series: | Journal of Hainan Medical University |
Subjects: | |
Online Access: | http://www.hnykdxxb.com/PDF/201721/35.pdf |
id |
doaj-ab1575f2978c4078bae30c951a59bc5b |
---|---|
record_format |
Article |
spelling |
doaj-ab1575f2978c4078bae30c951a59bc5b2020-11-25T00:53:13ZengEditorial Board of Journal of Hainan Medical UniversityJournal of Hainan Medical University1007-12371007-12372017-11-012321143146Effects of Ginaton combined with batroxobin on oxidative stress, hemodynamics and coagulation in SHL patientsYan Zhao0Shi-Jia Lai1Ru-Tao Ai2Jian-Ming Huang3Medical Examination Center, The 174 Hospital of PLA, Fujian, Xiamen 361003, ChinaMedical Examination Center, The 174 Hospital of PLA, Fujian, Xiamen 361003, ChinaMedical Examination Center, The 174 Hospital of PLA, Fujian, Xiamen 361003, ChinaDepartment of Orthopedics, The 174 Hospital of PLA, Fujian, Xiamen 361003, ChinaObjective: To investigate the effects of ginaton combined with batroxobin on oxidative stress, hemodynamics and coagulation in patients with sudden hearing loss. Methods: According to random data table method, 100 cases of sudden hearing loss were randomly divided into the control group (n=50) and observation group (n=50), patients in the control group were given batroxobin treatment, the observation group received ginaton combined with batroxobin theraphy.The levels of oxidative stress, hemodynamics and coagulation were compared between the two groups before and after treatment. Results: The levels of WBV, HCT, PV, APTT, PT, TT, PF, SOD, LPO in the two groups before treatment were not statistically significant. After treatment, the levels of WBV, PV in the control group and observation group were respectively (5.33±0.62) mPa•s, (1.73±0.59) mPa•s and (4.07±0.55) mPa•s, (1.32±0.41) mPa•s, which were significantly lower than those before treatment, and after treatment in the observation group the levels of WBV, PV were significantly lower than the control group; After treatment, the levels of APTT, PT, TT, PF in the control group and observation group were respectively (43.75±6.15) s, (18.23±2.02) s, (15.38±2.51) s, (58.61±12.96) µg/L and (53.68±7.16) s, (24.67±4.35) s, (22.51±4.85) s, (41.47±8.63) µg/L, compared with those in the same group before treatment, the levels of APTT, PT and TT were significantly increased, PF level was significantly decreased, and in the observation group APTT, PT and TT levels were significantly higher and PF level was significantly lower than that in the control group. After treatment, the levels of SOD, LPO in the control group and observation group were respectively (101.78±10.53) nu/L, (5.91±0.95) mmol/L and (110.07±12.62) nu/L, (4.68±1.02) mmol/L compared with those in the same group before treatment, the level of SOD were significantly increased, the level of LPO level was significantly decreased, and in the observation group LPO level was significantly lower and SOD level was significantly higher than that in the control group. Conclusion Compared with the use of batroxobin alone, Ginaton combined with batroxobin can better reduce the stress response, improve hemodynamics and coagulation in patients with sudden hearing loss.http://www.hnykdxxb.com/PDF/201721/35.pdfGinatonBatroxobinSudden hearing lossOxidative stressHemodynamicsCoagulation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yan Zhao Shi-Jia Lai Ru-Tao Ai Jian-Ming Huang |
spellingShingle |
Yan Zhao Shi-Jia Lai Ru-Tao Ai Jian-Ming Huang Effects of Ginaton combined with batroxobin on oxidative stress, hemodynamics and coagulation in SHL patients Journal of Hainan Medical University Ginaton Batroxobin Sudden hearing loss Oxidative stress Hemodynamics Coagulation |
author_facet |
Yan Zhao Shi-Jia Lai Ru-Tao Ai Jian-Ming Huang |
author_sort |
Yan Zhao |
title |
Effects of Ginaton combined with batroxobin on oxidative stress, hemodynamics and coagulation in SHL patients |
title_short |
Effects of Ginaton combined with batroxobin on oxidative stress, hemodynamics and coagulation in SHL patients |
title_full |
Effects of Ginaton combined with batroxobin on oxidative stress, hemodynamics and coagulation in SHL patients |
title_fullStr |
Effects of Ginaton combined with batroxobin on oxidative stress, hemodynamics and coagulation in SHL patients |
title_full_unstemmed |
Effects of Ginaton combined with batroxobin on oxidative stress, hemodynamics and coagulation in SHL patients |
title_sort |
effects of ginaton combined with batroxobin on oxidative stress, hemodynamics and coagulation in shl patients |
publisher |
Editorial Board of Journal of Hainan Medical University |
series |
Journal of Hainan Medical University |
issn |
1007-1237 1007-1237 |
publishDate |
2017-11-01 |
description |
Objective: To investigate the effects of ginaton combined with batroxobin on oxidative stress,
hemodynamics and coagulation in patients with sudden hearing loss. Methods: According
to random data table method, 100 cases of sudden hearing loss were randomly divided into
the control group (n=50) and observation group (n=50), patients in the control group were
given batroxobin treatment, the observation group received ginaton combined with batroxobin
theraphy.The levels of oxidative stress, hemodynamics and coagulation were compared
between the two groups before and after treatment. Results: The levels of WBV, HCT, PV,
APTT, PT, TT, PF, SOD, LPO in the two groups before treatment were not statistically
significant. After treatment, the levels of WBV, PV in the control group and observation group
were respectively (5.33±0.62) mPa•s, (1.73±0.59) mPa•s and (4.07±0.55) mPa•s, (1.32±0.41)
mPa•s, which were significantly lower than those before treatment, and after treatment in the
observation group the levels of WBV, PV were significantly lower than the control group;
After treatment, the levels of APTT, PT, TT, PF in the control group and observation group
were respectively (43.75±6.15) s, (18.23±2.02) s, (15.38±2.51) s, (58.61±12.96) µg/L and
(53.68±7.16) s, (24.67±4.35) s, (22.51±4.85) s, (41.47±8.63) µg/L, compared with those in the
same group before treatment, the levels of APTT, PT and TT were significantly increased, PF
level was significantly decreased, and in the observation group APTT, PT and TT levels were
significantly higher and PF level was significantly lower than that in the control group. After
treatment, the levels of SOD, LPO in the control group and observation group were respectively
(101.78±10.53) nu/L, (5.91±0.95) mmol/L and (110.07±12.62) nu/L, (4.68±1.02) mmol/L
compared with those in the same group before treatment, the level of SOD were significantly
increased, the level of LPO level was significantly decreased, and in the observation group
LPO level was significantly lower and SOD level was significantly higher than that in the
control group. Conclusion Compared with the use of batroxobin alone, Ginaton combined
with batroxobin can better reduce the stress response, improve hemodynamics and coagulation
in patients with sudden hearing loss. |
topic |
Ginaton Batroxobin Sudden hearing loss Oxidative stress Hemodynamics Coagulation |
url |
http://www.hnykdxxb.com/PDF/201721/35.pdf |
work_keys_str_mv |
AT yanzhao effectsofginatoncombinedwithbatroxobinonoxidativestresshemodynamicsandcoagulationinshlpatients AT shijialai effectsofginatoncombinedwithbatroxobinonoxidativestresshemodynamicsandcoagulationinshlpatients AT rutaoai effectsofginatoncombinedwithbatroxobinonoxidativestresshemodynamicsandcoagulationinshlpatients AT jianminghuang effectsofginatoncombinedwithbatroxobinonoxidativestresshemodynamicsandcoagulationinshlpatients |
_version_ |
1725238713130156032 |